CAL
GILD icon

Capital Analysts LLC’s Gilead Sciences GILD Stock Holding History

Capital Analysts LLC’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$946K Buy
6,792
+25
+0.4% +$3.5K 0.02% 342
2025
Q4 		$831K Buy
6,767
+113
+2% +$13.7K 0.02% 342
2025
Q3 		$739K Sell
6,654
-161
-2% -$18.3K 0.02% 358
2025
Q2 		$756K Buy
6,815
+211
+3% +$22.5K 0.03% 321
2025
Q1 		$740K Buy
6,604
+1,160
+21% +$120K 0.03% 306
2024
Q4 		$503K Buy
5,444
+426
+8% +$38.4K 0.02% 329
2024
Q3 		$421K Buy
5,018
+516
+11% +$39.4K 0.02% 352
2024
Q2 		$309K Buy
4,502
+2,204
+96% +$147K 0.01% 392
2024
Q1 		$168K Buy
2,298
+322
+16% +$24.8K 0.01% 472
2023
Q4 		$160K Sell
1,976
-5
-0.3% -$389 0.01% 455
2023
Q3 		$148K Buy
1,981
+174
+10% +$13.4K 0.01% 432
2023
Q2 		$139K Sell
1,807
-317
-15% -$25.3K 0.01% 419
2023
Q1 		$176K Buy
2,124
+102
+5% +$8.45K 0.01% 393
2022
Q4 		$174K Sell
2,022
-329
-14% -$26.1K 0.01% 412
2022
Q3 		$145K Buy
2,351
+17
+0.7% +$1.07K 0.01% 394
2022
Q2 		$145K Buy
2,334
+818
+54% +$50.6K 0.01% 378
2022
Q1 		$90K Sell
1,516
-218
-13% -$13.9K 0.01% 451
2021
Q4 		$126K Buy
1,734
+152
+10% +$10.5K 0.01% 411
2021
Q3 		$110K Buy
1,582
+361
+30% +$25.4K 0.01% 434
2021
Q2 		$84K Buy
1,221
+133
+12% +$8.88K 0.01% 483
2021
Q1 		$70K Buy
1,088
+12
+1% +$774 ﹤0.01% 532
2020
Q4 		$63K Buy
1,076
+13
+1% +$784 0.01% 387
2020
Q3 		$67K Buy
1,063
+11
+1% +$763 0.01% 364
2020
Q2 		$81K Buy
1,052
+10
+1% +$766 0.01% 299
2020
Q1 		$78K Buy
1,042
+10
+1% +$691 0.01% 282
2019
Q4 		$67K Buy
1,032
+9
+0.9% +$586 0.01% 353
2019
Q3 		$64K Buy
1,023
+10
+1% +$654 0.01% 344
2019
Q2 		$68K Buy
1,013
+10
+1% +$658 0.01% 328
2019
Q1 		$65K Buy
1,003
+603
+151% +$40.1K 0.01% 317
2018
Q4 		$25K Hold
400
– – ﹤0.01% 384
2018
Q3 		$31K Sell
400
-876
-69% -$66.2K ﹤0.01% 364
2018
Q2 		$90K Sell
1,276
-114
-8% -$8.05K 0.01% 260
2018
Q1 		$105K Hold
1,390
– – 0.01% 236
2017
Q4 		$100K Sell
1,390
-2,753
-66% -$209K 0.01% 239
2017
Q3 		$336K Buy
4,143
+423
+11% +$32.3K 0.05% 167
2017
Q2 		$263K Sell
3,720
-2,775
-43% -$185K 0.04% 177
2017
Q1 		$441K Sell
6,495
-2,342
-27% -$165K 0.07% 149
2016
Q4 		$633K Sell
8,837
-4,675
-35% -$347K 0.11% 132
2016
Q3 		$1.07M Sell
13,512
-1,302
-9% -$106K 0.2% 88
2016
Q2 		$1.24M Sell
14,814
-329
-2% -$29.2K 0.25% 79
2016
Q1 		$1.39M Buy
15,143
+1,204
+9% +$109K 0.28% 84
2015
Q4 		$1.41M Buy
13,939
+2,420
+21% +$252K 0.29% 85
2015
Q3 		$1.13M Buy
11,519
+925
+9% +$103K 0.22% 102
2015
Q2 		$1.24M Buy
10,594
+1,937
+22% +$212K 0.25% 91
2015
Q1 		$850K Buy
8,657
+3,790
+78% +$385K 0.18% 105
2014
Q4 		$459K Buy
4,867
+722
+17% +$74.7K 0.1% 112
2014
Q3 		$441K Sell
4,145
-61
-1% -$5.97K 0.1% 112
2014
Q2 		$349K Buy
4,206
+3,806
+952% +$296K 0.09% 119
2014
Q1 		$28.3K Hold
400
– – 0.01% 261
2013
Q4 		$30K Hold
400
– – 0.01% 245
2013
Q3 		$25.1K Hold
400
– – 0.01% 237
2013
Q2 		$20.5K Buy
+400
New +$20.8K 0.01% 250

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital Analysts LLC's GILD Position: Q1 2026 in Review

Capital Analysts LLC increased its Gilead Sciences (GILD) stake by 0.37% in Q1 2026, buying an estimated $3.5K and bringing the position to 6,792 shares worth $946K. The position accounts for 0.02% of the portfolio, ranked #342.

Capital Analysts LLC first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.41M in Q4 2015. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Capital Analysts LLC held 6,792 shares of Gilead Sciences worth $946K as of Q1 2026.
  • Capital Analysts LLC bought 25 Gilead Sciences shares in Q1 2026, an estimated $3.5K.
  • Gilead Sciences made up 0.02% of Capital Analysts LLC's portfolio in Q1 2026, its #342 holding.
  • Capital Analysts LLC first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • Capital Analysts LLC's Gilead Sciences position peaked at $1.41M in Q4 2015.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Capital Analysts LLC's 13F filing for Q1 2026, filed 14 May 2026.